Sanjay Subramanian - Mar 23, 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 23, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2023, 04:05 PM
Previous filing
Apr 20, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +135K $0.00 135K Mar 23, 2023 Common Stock 135K $3.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 23, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from April 23, 2023 through March 23, 2027.